Masaya Misaki Selected Research

Neurofeedback

3/2022	Neurofeedback-Augmented Mindfulness Training Elicits Distinct Responses in the Subregions of the Insular Cortex in Healthy Adolescents.
1/2022	Real-Time Functional Magnetic Resonance Imaging Dyadic Neurofeedback for Emotion Regulation: A Proof-of-Concept Study.
1/2021	Hippocampal volume recovery with real-time functional MRI amygdala neurofeedback emotional training for posttraumatic stress disorder.
1/2021	Real-time fMRI neurofeedback amygdala training may influence kynurenine pathway metabolism in major depressive disorder.
1/2020	Emotion self-regulation training in major depressive disorder using simultaneous real-time fMRI and EEG neurofeedback.
1/2019	Brain activity mediators of PTSD symptom reduction during real-time fMRI amygdala neurofeedback emotional training.
7/2018	Amygdala real-time functional magnetic resonance imaging neurofeedback for major depressive disorder: A review.
1/2018	Altered task-based and resting-state amygdala functional connectivity following real-time fMRI amygdala neurofeedback training in major depressive disorder.
1/2018	Real-time fMRI amygdala neurofeedback positive emotional training normalized resting-state functional connectivity in combat veterans with and without PTSD: a connectome-wide investigation.
1/2018	Real-time fMRI neurofeedback training of the amygdala activity with simultaneous EEG in veterans with combat-related PTSD.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masaya Misaki Research Topics

Disease

8	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2014
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 01/2018
3	Mental Disorders (Mental Disorder) 01/2022 - 01/2014
2	Anxiety Disorders (Anxiety Disorder) 01/2018 - 01/2017
1	Pain (Aches) 03/2022
1	Inflammation (Inflammations) 01/2018
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2018

Drug/Important Bio-Agent (IBA)

1	KynurenineIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Biological ProductsIBA 01/2017

Therapy/Procedure

15	Neurofeedback 03/2022 - 01/2014
1	Therapeutics 01/2018